Environmental Leader (Free subscription) | 25/11/2009
Bausch & Lomb’s world headquarters in Rochester, N.Y., has achieved Energy Star status from the EPA. That means the building uses at least 40 percent less energy than a similar building, while releasing 35 percent less carbon into the atmosphere, according to a press release. As part of the application process, Bausch & Lomb said it conducted [...]
Market Wire (Free subscription) | 24/11/2009
ROCHESTER, NY (MARKET WIRE) Bausch & Lomb's World Headquarters in Rochester, N.Y., has earned the Energy Star rating for energy efficiency from the U.S. Environmental Protection Agency (USEPA).
Fiercebiotech (Free subscription) | 18/11/2009
Peter Thompson , Trubion Pharmaceuticals' president, CEO, chairman of the board and co-founder, has retired. Steven Gillis , former lead director of Trubion's board, has been appointed executive chairman of the board and acting president. Michelle Burris , Trubion's senior vice president and chief financial officer, will assume the role of chief operating officer, and John Bencich , the company's...
Creative Minority Reader (Free subscription) | 15/11/2009
Brian Kopp has the skinny on wht looks to be a scam. Be very skeptical when it comes to self-proclaimed internet health gurus. For instance, Mike Adams of " NaturalNews " also owns a company that sells email marketing software, Arial Software . Be sure to check out their extensive client list . This is obviously not some obscure little guy fighting health care goliaths; Arial Software is...
thepharmaletter.com (Free subscription) | 13/11/2009
In what could likely be a string of new non-executive appointments, leading pharmaceutical industry player Fred Hassan has joined the board of directors of US global eye health company Bausch & Lomb.
Medical News Today (Free subscription) | 13/11/2009
Bausch & Lomb announced that the company's Lo-Torque® lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design. These findings from two clinical studies were presented at Academy 2009, the American Academy of Optometry annual meeting in Orlando, Fla.
Newswise (Free subscription) | 12/11/2009
Bausch & Lomb today announced that the company's Lo-Torque(r) lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design.
Red Orbit (Free subscription) | 12/11/2009
ROCHESTER, N.Y., Nov. 12 /PRNewswire/ -- Bausch & Lomb, the global eye health company, today announced that Fred Hassan has been elected to its Board of Directors. Mr.
Medical Device Recalls since November 03, 2006 (Free subscription) | 11/11/2009
Bausch & Lomb ReNu¿ Multi-Purpose Solution, 12 fl.oz. (355 ml), Bausch & Lomb, Incorporated, Rochester, NY 14609. Product is used for For the cleaning, rinsing, disinfecting, and storage of soft contact lenses.
PR News Wire (Free subscription) | 09/11/2009
ROCHESTER, N.Y., Nov. 9 /PRNewswire/ -- Skiers, snowboarders and other outdoor sports enthusiasts in North America have a new solution to one of the biggest problems they encounter -- fogging of goggles and face shields. Bausch & Lomb's new FogShield Sport(TM) pre-moistened towelettes simultaneously prevent fog from forming on goggles for eight hours or more and help keep lenses clean with just...
Contract Pharma Breaking News (Free subscription) | 04/11/2009
Pramod Gupta, Ph.D. has been appointed vice president of quality and chief scientific officer, Coldstream Laboratories, Inc. (CLI). In his new role, Dr. Gupta will focus on strengthening the company’s quality systems, R&D capabilities and overall project execution. Dr. Gupta has more than 20 years of experience in the pharmaceutical and medical device industries. Most recently, he served...
Fiercebiotech (Free subscription) | 03/11/2009
Atlanta-based Alimera Sciences has refiled its IPO, upping the ante to $80 million as it tests investors' appetite for biotech stock. Alimera, which is developing new drugs for retina diseases, dumped its original effort to raise $75 million in an IPO that was scuttled last spring by a severe setback in market confidence. The developer has raised $71 million in venture funds from Scale Venture Partners,...
BeCentsAble (Free subscription) | 31/10/2009
. . The November coupon book will be available on November 1st. The coupons expire on 11/28/09. •Ricola Cough Drops Natural Herb, 50 ct. - 50¢ off •Delsym Adult or Child, 5 oz. - $1 off •W Vitamin C or Organic Lip Balm, .15 oz. - $1 off •Chap-Aid Lip Balm 3 pack, Original or Cherry, .15 oz - 50¢ off •Carmex 3 Pack, Original or Cherry Squeeze Tube, .35 oz - $1 off...
Business Wire (Free subscription) | 29/10/2009
WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year contract with renowned eye health company Bausch & Lomb. The agreement calls for Bausch & Lomb to implement Phase Forward’s InForm™ Global Trial Management (GTM) electronic data capture (EDC) solution, including...
Jack's Perks (Free subscription) | 18/10/2009
Click on the links below for free contact lenses: Acuvue Bausch & Lomb Ciba
Videos